PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-94.66%
Both yoy net incomes decline, with CSIQ at -3.34%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
18.09%
Some D&A expansion while CSIQ is negative at -144.15%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
3.05%
Deferred tax of 3.05% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-17.23%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-115.10%
Negative yoy working capital usage while CSIQ is 286.32%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
109.33%
AR growth of 109.33% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-1446.12%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
292.60%
AP growth of 292.60% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-358.11%
Negative yoy usage while CSIQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
107.84%
Some yoy increase while CSIQ is negative at -981.38%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-119.63%
Negative yoy CFO while CSIQ is 475.97%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
61.42%
Some CapEx rise while CSIQ is negative at -107.68%. John Neff would see competitor possibly building capacity while we hold back expansions.
-89.58%
Negative yoy acquisition while CSIQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2709.17%
Both yoy lines negative, with CSIQ at -1625400.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-106.13%
Both yoy lines negative, with CSIQ at -101.12%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
107.83%
Debt repayment growth of 107.83% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
-7.89%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.